Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2003
07/17/2003WO2002011713A3 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
07/17/2003US20030135873 Transgenic animal model coding fusion protein comprising nuclear protein and herpes viral vp16 protein; antidiabetic agents; uncoupling proteins
07/17/2003US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor
07/17/2003US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics
07/17/2003US20030134891 N,N'-bis(2-carboxytetramethylene)adipamide or cyclic alkylene esters for use in the treatment or prevention of central and systemic amyloidosis.
07/17/2003US20030134888 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc.
07/17/2003US20030134882 Use of C2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity
07/17/2003US20030134881 Substituted with a thio, sulfoxy or sulfonyl group
07/17/2003US20030134879 Substituted with a thio, sulfoxy or sulfonyl group
07/17/2003US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003US20030134858 Treatment of inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease
07/17/2003US20030134850 Hydrazinyl and nitrogen oxide pyrazoles
07/17/2003US20030134847 New polycyclic azaindole compounds
07/17/2003US20030134840 Novel compounds
07/17/2003US20030134839 5-(Alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles
07/17/2003US20030134836 Substituted arylamine derivatives and methods of use
07/17/2003US20030134833 Substance for lowering high cholesterol level in serum and methods for preparing and using the same
07/17/2003US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate,
07/17/2003US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as
07/17/2003US20030134804 Rehydrating formulation
07/17/2003US20030134802 Novel effectors of dipepetidyl peptidase IV
07/17/2003US20030134787 Engineered to noncovalently bind to heat shock proteins; (ii) to compositions comprising such conjugate peptides, optionally bound to heat shock protein; and (iii) to methods of using such compositions to induce an immune response in a subject in
07/17/2003US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides
07/17/2003US20030134400 Isolation of genes that encode enzymes (Delta 4-desaturase) involved in the conversion of adrenic acid to omega 6-docosapentaenoic acid and omega 3-docosapentaenoic acid to docosahexaenoic acid
07/17/2003US20030134027 Comprises pectin, alginate, calcium, and fiber; dietetics
07/17/2003US20030133992 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
07/17/2003US20030133985 Controlled release oral dosage forms; data obtained using disintegration test such as the established USP Disintegration Test, rather than the results obtained using a standard USP Dissolution Test, as is conventionally done
07/17/2003US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen.
07/17/2003US20030133920 Koji molds for preparing cholesterol lowering products
07/17/2003US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes
07/17/2003US20030133902 Method of making phosphate-binding polymers for oral administration
07/17/2003CA2767061A1 Specific binding agents of human angiopoietin-2
07/17/2003CA2475173A1 Use of amylin agonists to modulate triglycerides
07/17/2003CA2473106A1 Pravastatin pharmaceutical formulations and methods of their use
07/17/2003CA2473097A1 Compositions including ammonia oxidizing bacteria and methods of using same
07/17/2003CA2473043A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
07/17/2003CA2472882A1 Modification of feeding behavior
07/17/2003CA2472585A1 Drug mixture with enhanced dissolution rate
07/17/2003CA2472331A1 Process and intermediates for pyridazinone antidiabetic agents
07/17/2003CA2472111A1 Human mast cell-expressed membrane proteins
07/17/2003CA2472049A1 Dominant negative proteins and methods thereof
07/17/2003CA2471957A1 Cyclic tetrapeptide compound and use thereof
07/17/2003CA2471951A1 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
07/17/2003CA2471885A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003CA2471880A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003CA2471768A1 Body weight gain inhibitor
07/17/2003CA2471566A1 Combination of mtp inhibitors or apob-secretion inhibitors with fibrates for use as pharmaceuticals
07/17/2003CA2471204A1 Inhibitors of dipeptidyl peptidase iv
07/17/2003CA2470012A1 Novel proteins and nucleic acids encoding same
07/17/2003CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors
07/17/2003CA2469052A1 Transdifferentiation of pancreatic acinar cells
07/17/2003CA2468700A1 Extended glucagon-like peptide-1 analogs
07/16/2003EP1327887A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation end products
07/16/2003EP1327448A1 Homeostasis-maintaining agents
07/16/2003EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137
07/16/2003EP1326972A2 Transporters and ion channels
07/16/2003EP1326971A2 Proteins and nucleic acids encoding same
07/16/2003EP1326867A2 Bridged piperazine derivatives
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
07/16/2003EP1326859A1 Quinazoline derivatives with anti-tumour activity
07/16/2003EP1326858A2 Piperidine compounds as anti-allergic
07/16/2003EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis
07/16/2003EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326837A1 Crystal forms of 1- 6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride
07/16/2003EP1326835A1 Benzamide compounds as apo b secretion inhibitors
07/16/2003EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003EP1326643A2 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
07/16/2003EP1326630A2 Use of glp-1 and glp-2 peptides
07/16/2003EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
07/16/2003EP1326618A2 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases
07/16/2003EP1326613A1 Use of substituted imidazo 1,2-a]pyridine-, imidazo 1,2-a]pyrimidine and imidazo 1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003EP1326604A2 Combination of at least two compounds selected from an at1-receptorantagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
07/16/2003EP1326591A2 Combination of statins and sorbitol dehydrogenase inhibitors
07/16/2003EP1326502A2 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
07/16/2003EP1326500A1 Encased food product with contrasting components
07/16/2003EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
07/16/2003EP1155000B1 2-aminopyridines containing fused ring substituents
07/16/2003EP1070069B1 Bicyclic hydroxamic acid derivatives
07/16/2003EP1054669B1 Use of thiadiazolo[4,3-a]pyridine derivatives
07/16/2003EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them
07/16/2003EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1
07/16/2003EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
07/16/2003EP0688365B1 Fertility regulation with transforming growth factor beta
07/16/2003CN1430620A Macrolides compound
07/16/2003CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430612A Hete rocyclic derivatives
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430603A Novel bicyclic compounds
07/16/2003CN1430596A New gamma selective retinoids
07/16/2003CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof
07/16/2003CN1430513A Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia
07/16/2003CN1430474A Tryptophan source from plants and uses therefor
07/16/2003CN1429612A Thirty-six ingredients capsule for treating diabetes
07/16/2003CN1429606A Blood-Sugar lowering particles containing astragalus root and pueraria root etc.
07/16/2003CN1429597A Medicine for growing and firming tooth and its preparation method
1 ... 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 ... 1298